FDA panel meets to discuss vaccines for kids, kicking off authorization process
(WASHINGTON) -- An advisory panel at the Food and Drug Administration will vote Tuesday on whether to move forward with authorizing vaccines for children ages 5-11.The vote will be the first step in a regulatory process for the two-shot Pfizer vaccine for kids. If... Read More.